Lv61
3030 积分 2022-07-20 加入
Costs of Drug Development and Research and Development Intensity in the US, 2000-2018
10天前
已完结
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
18天前
已完结
Drug repurposing: progress, challenges and recommendations
25天前
已完结
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race
2个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
2个月前
已完结
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
2个月前
已完结
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
5个月前
已完结
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer’s Disease
5个月前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
5个月前
已完结
Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease
5个月前
已完结
皖公网安备34019202002308
